ArticleNeuro-oncology advances
A phase Ib/IIa trial of 9 repurposed drugs combined with temozolomide for the treatment of recurrent glioblastoma: CUSP9v3.
Marc-Eric Halatsch et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
49 papers cite it
pooled ittrialcites it